IRVINE, CA -- (MARKET WIRE) -- November 09, 2006 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced it has commenced a new AquaSonix Therapy clinical trial with patients suffering with pain from osteoarthritis of the knee. The study group has been randomly divided into two groups: one group receives the actual sound pressure wave treatments, while the second control or placebo group, does not.
